Hercules Capital Inc
Insiders Buying Price: ($17.49 - $17.53)
52 Week Price Range: ($15.65 - $22.04)
Shares purchased: May 8th
SEC published: May 9th starting at 4:20 PM
Company Bio
Hercules Capital is a specialty finance company focused on providing financing solutions to high-growth, innovative venture capital-backed companies 1 in various technology, life sciences, and sustainable technology industries.
They offer structured debt with warrants, senior debt, and equity investments.
The company aims to maximize portfolio returns through current income and capital appreciation. Hercules Capital's headquarters are located at 1 North B Street, Suite 2000, San Mateo, California, 94401.
Recent News
May 8, 2025: Hercules Capital announced the date of its 2025 Annual Meeting of Stockholders, which will be held virtually on Wednesday, June 18, 2025. The proxy statement for the meeting was filed on April 24, 2025, and mailed to stockholders on record as of April 17, 2025.
May 1, 2025: Hercules Capital reported its financial results for the first quarter of 2025, announcing total gross debt and equity commitments of $1.02 billion and total gross fundings of $539.1 million. The company's net investment income was reported as $77.5 million, or $0.45 per share.
April 29, 2025: Hercules Capital declared a total cash distribution of $0.47 per share for the first quarter of 2025. This includes a base distribution of $0.40 per share and a supplemental distribution of $0.07 per share, with a record date of May 13, 2025, and a payment date of May 20, 2025.
SEC Filings
Director Thomas Fallon
Director DeAnne Aguirre
Director Robert Badavas
Director Gayle Crowell
Director Wade Loo
Director Nikos Theodosopoulos